tradingkey.logo

Nuwellis Inc

NUWE
4.391USD
+0.541+14.06%
交易中 美東報價延遲15分鐘
5.99M總市值
0.02本益比TTM

Nuwellis Inc

4.391
+0.541+14.06%

關於 Nuwellis Inc 公司

Nuwellis, Inc. is a commercial-stage medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.

Nuwellis Inc簡介

公司代碼NUWE
公司名稱Nuwellis Inc
上市日期Feb 16, 2012
CEOErb (John L)
員工數量38
證券類型Ordinary Share
年結日Feb 16
公司地址12988 Valley View Rd
城市EDEN PRAIRIE
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編55344
電話19523454200
網址https://www.nuwellis.com/
公司代碼NUWE
上市日期Feb 16, 2012
CEOErb (John L)

Nuwellis Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Erb (John L)
Erb (John L)
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
803.00
+803.00%
Dr. Archelle (Feldshon) Georgiou, M.D.
Dr. Archelle (Feldshon) Georgiou, M.D.
Independent Director
Independent Director
3.00
+3.00%
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
--
--
Dr. Maria Rosa Costanzo, M.D.
Dr. Maria Rosa Costanzo, M.D.
Independent Director
Independent Director
--
--
Mr. Neil P. Ayotte, Esq.
Mr. Neil P. Ayotte, Esq.
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
--
--
Mr. Michael (Mike) Mccormick
Mr. Michael (Mike) Mccormick
Lead Independent Director
Lead Independent Director
--
--
Mr. David Alan (Dave) Mcdonald
Mr. David Alan (Dave) Mcdonald
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Erb (John L)
Erb (John L)
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
803.00
+803.00%
Dr. Archelle (Feldshon) Georgiou, M.D.
Dr. Archelle (Feldshon) Georgiou, M.D.
Independent Director
Independent Director
3.00
+3.00%
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
--
--
Dr. Maria Rosa Costanzo, M.D.
Dr. Maria Rosa Costanzo, M.D.
Independent Director
Independent Director
--
--
Mr. Neil P. Ayotte, Esq.
Mr. Neil P. Ayotte, Esq.
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
--
--
Mr. Michael (Mike) Mccormick
Mr. Michael (Mike) Mccormick
Lead Independent Director
Lead Independent Director
--
--

收入明細

由於公司未披露,未能獲取相關數據
由於公司未披露,未能獲取相關數據
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 1月2日 週五
更新時間: 1月2日 週五
持股股東
股東類型
持股股東
持股股東
佔比
Sabby Management, LLC
5.41%
DRW Securities, LLC
2.14%
Bigger Capital Funds, LP
0.34%
Citi Investment Research (US)
0.13%
Tower Research Capital LLC
0.06%
其他
91.93%
持股股東
持股股東
佔比
Sabby Management, LLC
5.41%
DRW Securities, LLC
2.14%
Bigger Capital Funds, LP
0.34%
Citi Investment Research (US)
0.13%
Tower Research Capital LLC
0.06%
其他
91.93%
股東類型
持股股東
佔比
Investment Advisor/Hedge Fund
5.41%
Investment Advisor
2.18%
Hedge Fund
0.40%
Research Firm
0.13%
Individual Investor
0.02%
其他
91.87%

機構持股

更新時間: 1月1日 週四
更新時間: 1月1日 週四
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
20
134.31K
8.11%
+91.72K
2025Q3
18
13.52K
2.03%
+10.09K
2025Q2
27
9.97K
1.46%
+7.11K
2025Q1
26
140.31K
3.15%
+23.64K
2024Q4
25
113.78K
2.60%
+73.44K
2024Q3
29
65.32K
2.68%
+45.76K
2024Q2
28
42.02K
3.15%
+30.15K
2024Q1
26
9.25K
4.91%
+1.97K
2023Q4
26
6.22K
6.75%
+3.61K
2023Q3
35
1.28K
4.82%
-1.76K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Sabby Management, LLC
35.89K
2.16%
+32.37K
+918.85%
Sep 30, 2025
DRW Securities, LLC
36.08K
2.18%
+36.08K
--
Sep 30, 2025
Bigger Capital Funds, LP
5.69K
0.34%
+5.69K
--
Jun 09, 2025
Citi Investment Research (US)
1.15K
0.13%
+1.15K
--
Sep 30, 2025
Tower Research Capital LLC
1.03K
0.06%
+898.00
+680.30%
Sep 30, 2025
UBS Financial Services, Inc.
2.86K
0.17%
+979.00
+52.10%
Sep 30, 2025
Erb (John L)
803.00
0.02%
+803.00
--
Jun 10, 2025
SBI Securities Co., Ltd.
63.00
0%
+2.00
+3.28%
Sep 30, 2025
The Vanguard Group, Inc.
31.00
0%
--
--
Nov 30, 2025
BofA Global Research (US)
5.00
0%
+4.00
+400.00%
Sep 30, 2025
查看更多

持股ETF

機構名稱
佔比
暫無數據

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
Jul 02, 2025
Merger
42→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Dec 09, 2022
Merger
100→1
公告日期
除權除息日
類型
比率
Jul 02, 2025
Merger
42→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Jun 26, 2024
Merger
35→1
Dec 09, 2022
Merger
100→1
Dec 09, 2022
Merger
100→1
Dec 09, 2022
Merger
100→1
Dec 09, 2022
Merger
100→1
Oct 17, 2020
Merger
30→1
查看更多
KeyAI